Revisiting regulatory T cells for stroke therapy

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Stroke is a leading cause of death and long-term disability. T cells have been extensively studied for their dual role in regulating immunity and inflammation following stroke. In this issue of the JCI, Cai, Shi, et al. demonstrated that CD8+ regulatory-like T cells (CD8+ TRLs) are one of the earliest lymphocyte subtypes to enter the brain after experimental ischemic stroke. Using a mouse model of stroke and comprehensive experimental approaches, the authors found that CD8+ TRLs reduced both brain damage and functional deficits in both young and aged mice. These unique early responding regulatory T cells may also play a role in a wide array of other T cell-mediated neurological disorders.

Cite

CITATION STYLE

APA

Lee, J., & McCullough, L. D. (2022). Revisiting regulatory T cells for stroke therapy. Journal of Clinical Investigation, 132(15). https://doi.org/10.1172/JCI161703

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free